Comparative analysis of staging systems in AL amyloidosis

Eli Muchtar; Terry M. Therneau; Dirk R. Larson; Morie A. Gertz; Martha Q. Lacy; Francis K. Buadi; David Dingli; Suzanne R. Hayman; Prashant Kapoor; Wilson Gonsalves; Taxiarchis V. Kourelis; Rahma Warsame; Amie Fonder; Miriam Hobbs; Yi Lisa Hwa; Nelson Leung; Stephen Russell; John A. Lust; Yi Lin; Ronald S. Go; Steven Zeldenrust; Robert A. Kyle; S. Vincent Rajkumar; Shaji K. Kumar; Angela Dispenzieri

doi:10.1038/s41375-018-0370-z

Comparative analysis of staging systems in AL amyloidosis

Eli Muchtar, Terry M. Therneau, Dirk R. Larson, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Wilson Gonsalves, Taxiarchis V. Kourelis, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Nelson Leung, Stephen Russell, John A. Lust, Yi Lin, Ronald S. GoSteven Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar, Angela Dispenzieri

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	811-814
Number of pages	4
Journal	Leukemia
Volume	33
Issue number	3
DOIs	https://doi.org/10.1038/s41375-018-0370-z
State	Published - Mar 1 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-018-0370-z

Cite this

Muchtar, E., Therneau, T. M., Larson, D. R., Gertz, M. A., Lacy, M. Q., Buadi, F. K., Dingli, D., Hayman, S. R., Kapoor, P., Gonsalves, W., Kourelis, T. V., Warsame, R., Fonder, A., Hobbs, M., Hwa, Y. L., Leung, N., Russell, S., Lust, J. A., Lin, Y., ... Dispenzieri, A. (2019). Comparative analysis of staging systems in AL amyloidosis. Leukemia, 33(3), 811-814. https://doi.org/10.1038/s41375-018-0370-z

Comparative analysis of staging systems in AL amyloidosis. / Muchtar, Eli; Therneau, Terry M.; Larson, Dirk R.; Gertz, Morie A.; Lacy, Martha Q.; Buadi, Francis K.; Dingli, David; Hayman, Suzanne R.; Kapoor, Prashant ; Gonsalves, Wilson ; Kourelis, Taxiarchis V.; Warsame, Rahma; Fonder, Amie; Hobbs, Miriam; Hwa, Yi Lisa; Leung, Nelson; Russell, Stephen; Lust, John A.; Lin, Yi; Go, Ronald S.; Zeldenrust, Steven; Kyle, Robert A.; Rajkumar, S. Vincent ; Kumar, Shaji K.; Dispenzieri, Angela.

In: Leukemia, Vol. 33, No. 3, 01.03.2019, p. 811-814.

Research output: Contribution to journal › Letter › peer-review

Muchtar, E, Therneau, TM, Larson, DR, Gertz, MA , Lacy, MQ, Buadi, FK, Dingli, D, Hayman, SR, Kapoor, P , Gonsalves, W , Kourelis, TV, Warsame, R, Fonder, A, Hobbs, M, Hwa, YL, Leung, N, Russell, S, Lust, JA, Lin, Y, Go, RS, Zeldenrust, S, Kyle, RA, Rajkumar, SV , Kumar, SK & Dispenzieri, A 2019, 'Comparative analysis of staging systems in AL amyloidosis', Leukemia, vol. 33, no. 3, pp. 811-814. https://doi.org/10.1038/s41375-018-0370-z

Muchtar, Eli ; Therneau, Terry M. ; Larson, Dirk R. ; Gertz, Morie A. ; Lacy, Martha Q. ; Buadi, Francis K. ; Dingli, David ; Hayman, Suzanne R. ; Kapoor, Prashant ; Gonsalves, Wilson ; Kourelis, Taxiarchis V. ; Warsame, Rahma ; Fonder, Amie ; Hobbs, Miriam ; Hwa, Yi Lisa ; Leung, Nelson ; Russell, Stephen ; Lust, John A. ; Lin, Yi ; Go, Ronald S. ; Zeldenrust, Steven ; Kyle, Robert A. ; Rajkumar, S. Vincent ; Kumar, Shaji K. ; Dispenzieri, Angela. / Comparative analysis of staging systems in AL amyloidosis. In: Leukemia. 2019 ; Vol. 33, No. 3. pp. 811-814.

@article{87e118b8a9d0427288e38e7de7134064,

title = "Comparative analysis of staging systems in AL amyloidosis",

author = "Eli Muchtar and Therneau, {Terry M.} and Larson, {Dirk R.} and Gertz, {Morie A.} and Lacy, {Martha Q.} and Buadi, {Francis K.} and David Dingli and Hayman, {Suzanne R.} and Prashant Kapoor and Wilson Gonsalves and Kourelis, {Taxiarchis V.} and Rahma Warsame and Amie Fonder and Miriam Hobbs and Hwa, {Yi Lisa} and Nelson Leung and Stephen Russell and Lust, {John A.} and Yi Lin and Go, {Ronald S.} and Steven Zeldenrust and Kyle, {Robert A.} and Rajkumar, {S. Vincent} and Kumar, {Shaji K.} and Angela Dispenzieri",

note = "Funding Information: Acknowledgements The study was supported by the Jabbs Foundation (Birmingham, United Kingdom), the Henry J. Predolin Foundation (USA), and National Institutes of Health National Cancer Institute grant P50 CA186781. Funding Information: Conflict of interest MAG: Consultancy (Milleniu) and honoraria (Cel-gene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis); MQL: Research funding (Celgene); DD: Research funding (Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals); PK: Research funding (Takeda, Celgene, and Amgen); SKK: Consultancy (Celgene, Millennium, Onyx, Janssen, and BMS) and research funding (Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS); AD: Research funding (Celgene, Millennium, Pfizer, and Janssen), Travel grant (Pfizer). The remaining authors declare that they have no conflict of interest.",

year = "2019",

month = mar,

day = "1",

doi = "10.1038/s41375-018-0370-z",

language = "English (US)",

volume = "33",

pages = "811--814",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Comparative analysis of staging systems in AL amyloidosis

AU - Muchtar, Eli

AU - Therneau, Terry M.

AU - Larson, Dirk R.

AU - Gertz, Morie A.

AU - Lacy, Martha Q.

AU - Buadi, Francis K.

AU - Dingli, David

AU - Hayman, Suzanne R.

AU - Kapoor, Prashant

AU - Gonsalves, Wilson

AU - Kourelis, Taxiarchis V.

AU - Warsame, Rahma

AU - Fonder, Amie

AU - Hobbs, Miriam

AU - Hwa, Yi Lisa

AU - Leung, Nelson

AU - Russell, Stephen

AU - Lust, John A.

AU - Lin, Yi

AU - Go, Ronald S.

AU - Zeldenrust, Steven

AU - Kyle, Robert A.

AU - Rajkumar, S. Vincent

AU - Kumar, Shaji K.

AU - Dispenzieri, Angela

N1 - Funding Information: Acknowledgements The study was supported by the Jabbs Foundation (Birmingham, United Kingdom), the Henry J. Predolin Foundation (USA), and National Institutes of Health National Cancer Institute grant P50 CA186781. Funding Information: Conflict of interest MAG: Consultancy (Milleniu) and honoraria (Cel-gene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis); MQL: Research funding (Celgene); DD: Research funding (Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals); PK: Research funding (Takeda, Celgene, and Amgen); SKK: Consultancy (Celgene, Millennium, Onyx, Janssen, and BMS) and research funding (Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS); AD: Research funding (Celgene, Millennium, Pfizer, and Janssen), Travel grant (Pfizer). The remaining authors declare that they have no conflict of interest.

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85060567465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060567465&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0370-z

DO - 10.1038/s41375-018-0370-z

M3 - Letter

C2 - 30675009

AN - SCOPUS:85060567465

VL - 33

SP - 811

EP - 814

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -